Regulatory identification of BPA as an endocrine disruptor: Context and methodologyClaire Beausoleil, Cécile Michel, Claude Emond et al.|Molecular and Cellular Endocrinology|2018Cited by 119
Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Safety phase of randomized trial GORTEC 2017-01 (REACH)Yungan Tao, Jean Bourhis, Laurent Martin et al.|Annals of Oncology|2019Cited by 6